RTP drug manufacturer eyes more growth with new private equity owners

A fast-growing drug manufacturer with 1,000 workers and locations in Research Triangle Park and Wilmington has been scooped up by private equity firms, including one led by former Quintiles executives.

Strategic Voices: What VanTrust Real Estate’s EVP says on state of office, industrial

Commerce Bank ranked among top banks in the country

Housing market’s October big chill in Colorado wasn’t limited to the Front Range

Houston lags when it comes to public funding, access to parks, new report says

How the region benefits when the arts get “kinda weird”

$9.3 million sale leads latest Top of the Market

Why one prominent Jax web3 bull is still bullish since the crash

N.C. A&T plans $32M dorm to tackle housing challenges

RTP drug manufacturer eyes more growth with new private equity owners

Previous BMO Harris hit with record $564 million verdict in Tom Petters Ponzi scheme case

Next New restaurants coming to Kyle, including Chipotle, Crust Pizza, Spoon + Fork

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Lockton Cos. continues to grow on the principles its founder built

3 reasons why Virta Health is moving its HQ from San Francisco to Denver, according to the CEO

Record loan from Housing Trust funds land for more than 300 affordable housing units near Diridon

Atlas Restaurant Group unveils vision for new Harbor East steakhouse

Northside restaurant Tickle Pickle opening second location inside of Listermann Brewing Co.

Indus Realty Trust looks to annex large Gaston County site off Interstate 85

MENU

FirstStar Group

More Stories

Report: Wells Fargo faces fine of up to $1 billion